RayanaAI
Account
CAI
HOLD / NEUTRALMeanRev
Composite
52.80
Technical
31.20
Fundamental
60.00
Rank
—
Price
17.06
Hurst
-0.02
As of
Jul 14, 2026
Daily
Caris Life Sciences, Inc.
HealthcareBiotechnology

Caris Life Sciences is an artificial intelligence and biotechnology company that offers molecular profiling services combining genetic sequencing with machine learning algorithms. Its product line includes tissue and blood-based sequencing tests for cancer detection, treatment selection, and monitoring of residual disease, along with research services for pharmaceutical companies. The company serves hospitals, medical institutions, and patients primarily in the United States and internationally, operating from its headquarters in Irving, Texas.

Market cap
$9.7B
P/E (trailing)
20.31
P/E (forward)
92.30
PEG ratio
—
Dividend yield
0.00%
Beta
—
52w range
14.19 – 36.50
Return on equity
+20.13%
Profit margin
+10.62%
Revenue growth
+45.40%
Earnings growth
—
Price history

1Y: 34.33 (+14.1%) · range 14.55–36.14

Cycle position
81/ 100 cycle scoreEXIT ZONE
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT

entry readiness 0 · NOT READY · exit proximity 43

Conviction
24/ 100 · maturity 57%
VScore.2811
Buildup.2443
EMA entry setup.300
Fundamentals.1860
Volume profile
POC
15.75
Price vs POC
+117.9%
Overhead supply
2%
Runway
open sky

Value area 14.19–27.58 · 2% of 120d volume overhead · clean runway

Contributing sources
SourceScoreLast seen
trend-signal
0.347
Oct 12, 2026
Forward returns
HorizonReturnMFEState
20d+72.03%+79.67%mature
40d+106.99%+106.99%mature